Hellp, Microangiopathic Hemolytic Anemia, and Preeclampsia

References

• Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol. 1982; 142: 159–67
   PubMed Web of Science ®Google Scholar
• Martin JN, Blake PG, Perry KG, McCaul JF, Hess LW, Martin R W. The natural history of HELLP syndrome: patterns of disease progression and regression. Am J Obstet Gynecol. 1991; 164: 1500–13
   PubMed Web of Science ®Google Scholar
• Van Dam PA, Renier M, Baekelandt M, Buytaert P, Nyttenbroeck F. Disseminated intravascular coagulation and the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia. Obstet Gynecol. 1989; 73: 97–102
   PubMed Web of Science ®Google Scholar
• Weinstein L. Preeclampsia/eclampsia with hemolysis, elevated liver enzymes, and thrombocytopenia. Obstet Gynecol. 1985; 66: 657–60
   PubMed Web of Science ®Google Scholar
• Aarnoudse JC, Houthoff HJ, Weits J, Wellenga E, Huisies H J. A syndrome of liver damage and intravascular coagulation in the last trimester of normotensive pregnancy. a clinical and histopathological study. Br J Obstet Gynecol. 1986; 93: 145–55
   PubMedGoogle Scholar
• Dantzer M, Rigaud P, Agnani G, Maillet R, Colett C. Le “HELLP syndrome” peut précéder l'apparition de l'hypertension artérielle au cours de la toxémie gravidique. Rev Fr Gynecol Obstet. 1987; 82: 243–5
   PubMedGoogle Scholar
• Monnier JC, Vaskmann S, Vinatier D, Savatier PP, Maussoury-Lefebvre C. Faut-il individualiser le HELLP syndrome?. J Gynecol Obstet Biol Reprod. 1987; 16: 765–71
   PubMedGoogle Scholar
• De Voe SJ, Shaughnessy R O. Clinical manifestations and diagnosis of pregnancy-induced hypertension. Clin Obstet Gynecol. 1984; 27: 836–53
   PubMed Web of Science ®Google Scholar
• De Vries JIP, Vellenga A, Aarnoudse J G. Plasma beta-thromboglobulin in normal pregnancy and pregnancy induced hypertension. Eur J Obstet Gynec Reprod Biol. 1983; 14: 209–14
   PubMed Web of Science ®Google Scholar
• El-Roey A, Myers SA, Gleicher N. The relationship between autoantibodies and intrauterine growth retardation in hypertensive disorders of pregnancy. Am J Obstet Gynecol. 1991; 164: 1253–61
   PubMed Web of Science ®Google Scholar
• Gibson B, Hunter D, Neame PB, Kelton J G. Thrombocytopenia in preeclampsia and eclampsia. Semin Thromb Hemostas. 1982; 8: 234–9
   PubMed Web of Science ®Google Scholar
• Stratta P, Canavese C, Colla L, Dogliani M, Iberti M, Veronesi GV, Vercellone A. Microangiopathic hemolytic anemia and post partum acute renal failure. Nephron. 1986; 44: 253–5
   PubMed Web of Science ®Google Scholar
• Weiner C P. The clinical spectrum of preeclampsia. Am J Kidney Dis. 1987; 9: 312–6
   PubMed Web of Science ®Google Scholar
• Martin JN, Files JC, Blake P G. Plasma exchange for preeclampsia-eclampsia with HELLP syndrome. Am J Obstet Gynecol. 1990; 162: 126–37
   PubMed Web of Science ®Google Scholar
• Poldre P A. Haptoglobin helps diagnose the HELLP syndrome. Am J Obstet Gynecol. 1987; 157: 1267
   PubMed Web of Science ®Google Scholar
• Page E W. On the pathogenesis of preeclampsia and eclampsia. J Obstet Gynaecol Br Commonw. 1972; 79: 883–9
   PubMedGoogle Scholar
• Pritchard JA, Weisman R, Ratnoff VD, Vosburgh G. Intravascular hemolysis, thrombocytopenia and other hematologic abnormalities associated with severe toxemia of pregnancy. N Engl J Med. 1954; 250: 87–96
   PubMed Web of Science ®Google Scholar
• Pritchard JA, Cunningham FG, Mason R A. Coagulation changes in eclampsia: their frequency and pathogenesis. Am J Obstet Gynecol. 1976; 124: 885–92
   Web of Science ®Google Scholar
• Tchobroutsky C, Bernuau H, Jorrot JC, Hosanski M. Le syndrome HELLP: une forme particuliere de l'hypertension de la grossesse. J Gynecol Obstet Biol Reprod. 1989; 18: 325–30
   PubMedGoogle Scholar
• Friedman S A. Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol. 1988; 71: 122
   PubMed Web of Science ®Google Scholar
• Worley R J. Pathophysiolog of pregnancy-induced hypertension. Clin Obstet Gynecol. 1984; 27: 821–34
   PubMedGoogle Scholar
• Tulenko T, Schneider J, Floro C, Sicilla M. The in vitro effect on arterial wall function of serum from patients with pregnancy-induced hypertension. Am J Obstet Gynecol. 1987; 156: 817–23
   PubMed Web of Science ®Google Scholar
• Maseki M, Nishigaki J, Hagihara M, Tomoda Y, Yagi K. Lipid peroxide levels and lipid content of serum lipoprotein fraction of pregnant subjects with or without preeclampsia. Clin Chem Acta. 1981; 115: 158–61
   Web of Science ®Google Scholar
• Wickens D, Wilkins MH, Lunec J, Ball G, Dormandy T L. Free-radical oxidation (peroxidation) products in plasma in normal and abnormal pregnancy. Ann Clin Biochem. 1981; 18: 158–62
   PubMed Web of Science ®Google Scholar
• Gleicher N, El-Roey A, Confino E, Friberg J. Reproductive failure because of autoantibodies: unexplained infertility and pregnancy wastage. Am J Obstet Gynecol. 1989; 160: 1376–85
   PubMed Web of Science ®Google Scholar
• Milliez J, Latrous H, El Medjadji M. The prevalence of autoantibodies during third-trimester pregnancy complicated by hypertension or idiopathic fetal growth retardation. Am J Obstet Gynecol. 1991; 165: 51–6
   PubMed Web of Science ®Google Scholar
• Bussolino F, Benedetto C, Massobrio M, Camussi G. Maternal vascular prostacyclin activity in preeclampsia [Letter]. Lancet. 1980; ii: 702
   Google Scholar
• Remuzzi G, Marchesi D, Zoja C. Reduced umbilical vascular prostacyclin in severe preeclampsia. Prostaglandins 1980; 20: 105–10
   PubMed Web of Science ®Google Scholar
• Stratta P, Canavese C, Bussolino F, Mansueto MG, Gagliardi G, Vercellone A. Haemolytic abortive syndrome [Letter]. Lancet. 1983; i: 424–5
   Google Scholar
• Musci TJ, Roberts JM, Rodgers GM, Taylor R N. Mitogenic activity is increased in the sera of preeclamptic women before delivery. Am J Obstet Gynecol. 1988; 159: 1446–51
   PubMed Web of Science ®Google Scholar
• Pinto A, Sorrentino R, Sorrentino P, Guerritore T, Miranda Lea, Biondi A, Martinelli P. Endothelial-derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension. Am J Obstet Gynecol. 1991; 164: 507–13
   PubMed Web of Science ®Google Scholar
• Stubbs TM, Lazarchick J, Horger E O. Plasma fibronectin levels in preeclampsia: a possible biochemical marker for vascular endothelial damage. Am J Obstet Gynecol. 1984; 150: 885–7
   PubMed Web of Science ®Google Scholar
• Koenig JM, Christensen. The mechanism responsible for diminished neutrophil production in neonates delivered of women with pregnancy-induced hypertension. Am J Obstet Gynecol. 1991; 165: 467–73
   PubMed Web of Science ®Google Scholar
• Wallenburg HCS, Rotman N. Enhanced reactivity of the platelet thromboxane pathway in normotensive and hypertensive pregnancies with insufficient fetal growth. Am J Obstet Gynecol. 1982; 144: 523–528
   PubMed Web of Science ®Google Scholar
• Beaufils M, Donsimoni R, Uzan S, Colan J C. Prevention of preeclampsia by early antiplatelet therapy. Lancet. 1985; 11: 840–2
   Google Scholar
• Benigni A, Gregorini G, Frasca T, Chiabrando C, Ballerini S, Valcamonica A, Orisio S, Piccinelli A, Pinciroli V, Fanelli R, Gastaldi A, Remuzzi G. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. N Engl J Med. 1989; 321: 357–62
   PubMed Web of Science ®Google Scholar
• Wallenburg HCS, Makovitz JW, Dekker GA, Rotmans P. Low-dose aspirin prevents pregnancy-induced hypertension and preeclampsia in angiotensin-sensitive primigravidae. Lancet. 1986; i: l–3
   Google Scholar
• Wallenburg HCS, Rotmans N. Prevention of recurrent idiopathic fetal growth retardation by low-dose aspirin and dypiridomole. Am J Obstet Gynecol. 1987; 157: 1230–5
   PubMed Web of Science ®Google Scholar
• Wallenburg HCS. Prevention of hypertensive disorders in pregnancy. Clin Exp Hyper Pregnancy 1988; 137: 121–37
   Google Scholar
• Wallenburg HCS, Dekker GA, Makovitz JW, Rotmans N. Effect of low-dose aspirin on vascular refractoriness in angiotensin-sensitive primigravid women. Am J Obstet Gynecol. 1991; 164: 1169–73
   PubMed Web of Science ®Google Scholar
• Remuzzi G. HUS and TTP: variable expression of a single entity. Kidney Int. 1987; 32: 292–308
   PubMed Web of Science ®Google Scholar
• Vercellone A, Stratta P, Canavese C. Hemolytic uremic syndrome. Acute Renal Failure, A Amerio, P Coratelli, V Campese, S E Massry. Plenum, Boston 1987; 185–98
   Google Scholar
• Stratta P. Hemorrheological approach to thrombotic microangiopathies. Nephron. 1985; 40: 67–73
   PubMed Web of Science ®Google Scholar
• Wallenburg HCS. Placental insufficiency: pathophysiology and therapeutic approaches. Triangle. 1990; 29: 171–9
   Google Scholar
• Wallenburg HCS. Clinical aspects of preeclampsia. In: MassobrioM, Benedetto C, eds. Gestosi 91. Ipertensione in Gravidanza. Rome:CIC Ed. 1991; 23–33
   Google Scholar
• Collins R, Wallenburg HCS. Pharmacological prevention and treatment of hypertensive disorders in pregnancy. Effective Care in Pregnancy and Childbirth, J Chalmers, M Enkin, MJM Keirze. Oxford University Press. 1989; 512–33
   Google Scholar
• Redman CWG. Fetal outcome in trial of anthihypertensive treatment in pregnancy. Lancet. 1976; ii: 753–6
   Google Scholar
• Sibai B M. Eclampsia. VI. maternal-perinatal outcome in 254 consecutive cases. Am J Obstet Gynecol. 1990; 163: 1049–55
   PubMed Web of Science ®Google Scholar
• Wallenburg HCS. Detecting hypertensive disorders of pregnancy. Effective Care in Pregnancy and Childbrith, I Chalmers, M Enkin, MJNC Keirse. Oxford University Press. 1989; 382–402
   Google Scholar
• Eknoyan G, Riggs S A. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Textbook of Nephrology, S G Massry, R J Glassock. Williams and Wilkins, Baltimore 1989; 732–8
   Google Scholar